Archived Content
This page is archived and provided for historical reference. The content is no longer being updated, and some of the information may have changed over time and could be outdated or inaccurate.
May 12, 2022
Director's Voice Blog
15 Years of Recognizing Behavioral and Social Sciences Research Excellence at NIH
Since 2006, the OBSSR annually hosts an event to celebrate Dr. Matilda White Riley’s influence and contributions to the social and behavioral sciences. In its 15th year, the NIH Matilda White Riley Behavioral and Social Sciences Honors will be held virtually on Friday, June 3, 2022, from 1:00 p.m. to 4:30 p.m. ET. This half-day event features a keynote address from the 2022 Distinguished Lecturer, Dr. David R. Williams, and highlights innovative research from five Early-Stage Investigator (ESI) Honorees, who were selected out of more than 250 submissions to our ESI paper competition. I hope you will join us in learning from and celebrating the accomplishments of these excellent scholars. Register today: https://www.scgcorp.com/mwrhonors2022/
Behavioral and Social Sciences Research Spotlights

The neurons that drive competition and social behavior within groups have been identified in mice
Research supported by the NINDS, NICHD, and others has identified neurons in the brain that influence competitive behavior and are involved in shaping social behavior of groups in a mouse model. Social interactions in people, as well as in other animals often happen in large groups, and these group interactions are important in sociology, ecology, psychology, and economics. However, the exact brain processes that are responsible for the complex dynamic behavior of social groups is not well understood, partly due to much of neuroscience research being focused on the behaviors of pairs of individuals interacting in isolation. In contrast, the current study investigated the behavior of large groups of mice during competitive group interactions.
Learn More

Social connections influence the brain structure of nonhuman primates
Social relationships are driven by factors like status and alliances and in the context of primates which thrive in large complex social groups. The large computational demands of living in large, complex social groups has been hypothesized to be a crucial factor driving the evolution of the primate brain size. However, whether and how the diverse components of primates’ natural social lives relate to brain structure remain largely unexplored., these factors may be linked to primate brain size over time. In a recent study funded by the NIMH, NIA, NSF, and others sought to understand the relationship between primate neuroanatomy and social factors in free-ranging rhesus macaques.
Read More

Socioeconomic factors affect patient outcomes for those being treated with pharmacotherapy for depression despite receiving equal access to care
Recently published research supported by the NIMH, NICHD, and others examined the impact of socioeconomic factors on pharmacotherapy treatment outcomes among adults with major depressive disorder (MDD). The research suggests that individuals who are socioeconomically disadvantaged (e.g., no college degree, unemployed, low income) demonstrate worse mental health outcomes than persons with higher socioeconomic status.
Go There Now
News and Events
Register: Dr. David R. Williams and ESI Honorees on June 3

15th NIH Matilda White Riley Behavioral and Social Sciences Honors
Friday, June 3, 2022
1:00 p.m. to 4:30 p.m. ET (virtual event)
Register and view the agenda and speaker biographies: https://www.scgcorp.com/mwrhonors2022
2022 NIH Matilda White Riley Distinguished Lecturer: David R. Williams, Ph.D., M.P.H.
Florence & Laura Norman Professor of Public Health
Chair, Department of Social & Behavioral Sciences,
Harvard Chan School of Public Health
Professor of African and African American Studies,
Harvard University
Presenting: The Virus of Racism: Understanding its Threats, Mobilizing Defenses
2022 NIH Matilda White Riley ESI Honorees and Presentations: Noli Brazil, Ph.D., University of California, Davis
The multidimensional clustering of health and its ecological risk factors
Keita Christophe, Ph.D., McGill University
Shift-&-Persist and discrimination predicting depression across the life course: An accelerated longitudinal design using MIDUS I-III
Patricia Homan, Ph.D., Florida State University
Structural intersectionality as a new direction for health disparities research
John W. Jackson, Sc.D., Johns Hopkins University
Meaningful causal decompositions in health equity research
Alina I. Palimaru, Ph.D., RAND Corporation
Mental health, family functioning, and sleep in cultural context among American Indian/Alaska Native urban youth: A mixed methods analysis
Health Communication Research RFI (May 27) and upcoming Workshop (May 16)
The NIH Common Fund is hosting a public workshop to bring together key representatives from multiple sectors with an interest in and that are influenced by health and science communication research to identify research opportunities and gaps that, if addressed, would lead to more effective communication towards promoting healthy behavior. Register for the workshop here to hear perspectives from health communication research, media and technology sectors, and community representatives on May 16, 2022, from 1-4 p.m. EDT. For more information about the workshop, please go to: https://commonfund.nih.gov/healthcommresearch.
The NIH is looking for information to help develop planning activities to inform a potential Common Fund research program to support the development of novel approaches to address health and science communication in a changing sociocultural landscape. To learn more, please see the RFI posted here. Responses are voluntary, and should be submitted electronically on the submission website. Responses are requested by 11:59:59 p.m. ET on Friday, May 27, 2022. To ensure consideration, responses must be received by the May 27th deadline.
NIH Scientific Workforce Diversity Seminar Series: How Does Diversity Impact Science?
NIH Scientific Workforce Diversity Seminar Series:
How Does Diversity Impact Science?
Tuesday, May 17, 2022
1:00 p.m. ET
Join the NIH Chief Officer for Scientific Workforce Diversity (COSWD) Office for the final Scientific Workforce Diversity Seminar Series (SWDSS) event of the 2021-2022 season, "How Does Diversity Impact Science?".
Dr. Marie A. Bernard, the NIH COSWD, will moderate a discussion on the impact of workforce diversity on creativity and innovation in science. Panelists will share their perspectives on the benefits of scientific workforce diversity and highlight effective methods for measuring its impact, as well as areas for future research.
NIH Director's Lecture: Damien Fair, Ph.D., on June 1
The Future of Non-invasive Functional Imaging in the Era of Big Data
Wednesday, June 1, 2022
3:00 p.m. to 4:00 p.m. ET
Speaker:
Damien Fair, Ph.D.
Professor, Institute of Child Development
Professor, Department of Pediatrics
Redleaf Endowed Director, Masonic Institute for the Developing Brain
University of Minnesota
Summary:
The Fair laboratory focuses on mechanisms and principles that underlie the developing brain. The majority of this work uses functional MRI and resting state functional connectivity MRI to assess typical and atypical populations. Dr. Fair is the co-director of the new Masonic Institute for the Developing Brain.
SBE COVID Coordinating Center Website
The Social, Behavioral, and Economic COVID Coordinating Center (SBE CCC), led by ICPSR, provides a nexus for communication on COVID-19 related research, streamlining information-sharing across the behavioral and social science community, multiple NIH award recipients, and the public. It promotes collaborative work across a multidisciplinary research community, each with different missions, cultures, and ethos. In addition, the project provides teaching materials, data, and opportunities to apply for pilot studies on the impacts of COVID-19 among minority populations.
SBE CCC works with members of the SBE COVID Consortium, a group of NIH-funded teams investigating the social, behavioral, and economic impacts of the COVID-19 pandemic.
The SBE CCC website is now live. The website includes news and announcements, webinars and podcasts, and featured publications, all on topics related to SBE COVID research.
Release of PATH Study Data Tables and Figures
The Population Assessment of Tobacco and Health (PATH) Study is a nationally representative, longitudinal cohort study of tobacco use and how it affects the health of people in the United States. A collaboration between the National Institutes of Health (NIH) and the Food and Drug Administration (FDA), the PATH Study was launched in 2011 and the first wave of data collection started in 2013. It is one of the first large tobacco research efforts undertaken by the NIH and the FDA since Congress gave the FDA authority to regulate tobacco products in 2009. A series of cross-sectional and longitudinal tables and figures providing national estimates on tobacco use among youth (aged 12-17), young adults (aged 18-24), and adults (aged 25+) using data from Waves 1-5 (2013-2019) of the PATH Study are now are available for public use at PATH Study Data Tables and Figures: Wave 1-5 (2013-2019). These tables and figures provide estimates stratified by age, sex, race/ethnicity, and educational attainment to provide information on differences in tobacco use patterns across these important demographic subgroups. Learn more about the PATH Study at https://doi.org/10.3886/Series606.
Recently Published Funding Announcements
RFI: Challenges and Opportunities in Health and Science Communication Research
Notice Number
NOT-RM-22-012
Key Dates
Release Date: April 26, 2022
Response Date: May 27, 2022
Purpose
The purpose of this Request for Information (RFI) is to solicit input from the broad community regarding opportunities and challenges in health and science communication research.
RFI: Identification of a Set of Determinants for Whole Person Health
Notice Number
NOT-AT-22-019
Key Dates
Release Date: April 4, 2022
Response Date: June 17, 2022
Purpose
The purpose of this Request for Information (RFI) is to solicit public comment on defining a set of key determinants of health that addresses all the elements of the whole person health model, i.e., factors that can influence health either positively or negatively, and that encompass the full continuum of biological, behavioral, social, and environmental domains.
NOSI: IMPROVE Initiative: Implementation Science to Advance Maternal Health and Maternal Health Equity
Notice Number
NOT-OD-22-125
Key Dates
First Available Due Date: June 5, 2022
Expiration Date: July 17, 2022
Purpose
The purpose of this Notice of Special Interest (NOSI) is to stimulate dissemination and implementation research on innovative approaches built on evidence-based findings from foundational research on factors that contribute to maternal morbidity and mortality (MMM). This NOSI will support the development and implementation of strategies to inform integrated efforts involving policy and practice changes to improve preconception, pregnancy, perinatal, and postpartum care and advance maternal health and maternal health equity.
NOSI: Administrative Supplements for Research of Emerging and Existing Issues of COVID-19 Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities
Notice Number
NOT-HD-22-003
Key Dates
First Available Due Date: April 29, 2022
Expiration Date: June 6, 2024
Purpose
The purpose of this funding opportunity is to provide an opportunity for funded researchers in these various fields to pursue supplemental funding to conduct research addressing these emerging and other existing COVID-related issues among pregnant and lactating people, infants, children and adolescents, and individuals with physical and/or intellectual disabilities. The goal of this NOSI is to not replace or to compete with the various COVID-related funding opportunities currently available. Instead, the purpose is to complement them by offering a funding opportunity for currently funded investigators to address key issues not currently covered by available COVID-related funding announcements among these populations.
BSSR Accomplishments
The NIH has been an instrumental leader in shaping and supporting behavioral and social sciences research (BSSR) to improve the nation’s health. Integrated with advances in other scientific disciplines, BSSR has made substantial contributions to the prevention or treatment of numerous physical health and mental health conditions.
In collaboration with subject matter experts from Institutes, Centers, and Offices across NIH, OBSSR has summarized some of the important scientific advances that demonstrate the valuable contribution of BSSR across various health conditions and behaviors. These summaries are provided as fact sheets (PowerPoint slides forthcoming) that highlight a significant public health problem and the corresponding BSSR-informed approaches used to address the problem. Various audiences such as academic researchers, public health organizations, and other health federal agencies, may find these materials useful to demonstrate to their stakeholders the importance of BSSR to the health of the United States population.
These new BSSR accomplishment resources are available on the OBSSR website:
Improving Sleep
Managing Chronic Pain
Preventing and Treating Diabetes
Preventing Intimate Partner Violence
Reducing Teen Pregnancy
Reducing Tobacco Use
Treating Depression
Treating Obsessive-Compulsive Disorder
Treating Phobias
Treating Post-Traumatic Stress Disorder
Additional BSSR accomplishments will be added to the website in 2023.
BSSR Clinical Trials Resources
The Clinical Trials Protocol Template for the Behavioral and Social Sciences is a resource for communicating the science, methods, and operations of a clinical trial. This template is a suggested format for clinical trials that are testing a behavioral or social intervention or experimental manipulation. Use of the protocol template is encouraged but not required.
The Behavioral and Social Clinical Trials Template was derived from the successful NIH-FDA Phase 2/3 IND-IDE Clinical Trial Template but was adapted to include terminology and approaches used by behavioral and social scientists. While the template is a suggested format for clinical trials that are testing a behavioral or social intervention or manipulation for which a stand-alone clinical protocol is required, the template can also be a useful tool for those trials funded by NIH Institutes or Centers that do not require stand-alone clinical protocols. Using the template to anticipate decision points and potential challenges before a study launches can help avoid subsequent delays and problems.
The DECISION SUPPORT TOOL: Features to Consider in Determining if a Clinical Trial is Phase II or Phase III is the result of a working group led by OBSSR, with participants from other NIH Institutes, Centers, and Offices. It is a designed to be a resource to help investigators, program officers, and reviewers determine if a behavioral or social science study is better characterized as a Phase II or a Phase III clinical trial. Distinguishing earlier phases of clinical trials (Phase 0 or I) is not usually difficult but distinguishing between a Phase II and III study can be more challenging, particularly for non-drug trials. Being thoughtful about this distinction is important for a variety of reasons, not least of which is that a Phase III designation for an NIH funded clinical trial generally requires following additional policies and practices beyond those that already apply to Phase II clinical trials, such as the requirement for valid analysis and for a Data and Safety Monitoring Board (DSMB). Data and safety monitoring are required for all clinical trials but for a Phase III trial, the constitution of a board is required.
NIH’s definition of a Phase III Clinical Trial is quite broad, including drug studies, device studies, behavioral interventions, epidemiological studies, community trials, and more. Phase III trials are usually large, prospective trials that compare two or more interventions against other standard or experimental interventions. In this next episode of our NIH All About Grants podcast (MP3 / Transcript) we explain what a Phase III trial is, how it compares to other types of clinical trials, considerations for your application and its review, how these studies influence standards of care, helpful tools and other resources, and much more. The guests include Ms. Dawn Corbett, NIH’s Inclusion Policy Officer, and Dr. Christine Hunter, OBSSR Acting Director.
Social and Behavioral Good Clinical Practice eCourse
In September 2016, the NIH issued a Policy on Good Clinical Practice (GCP) Training for NIH Awardees Involved in NIH-funded Clinical Trials. GCP is an international ethical and scientific quality standard for designing, conducting, recording and reporting clinical trials. The principles of GCP help assure the safety, integrity, and quality of clinical trials. Investigators and clinical trial staff who are competent in GCP principles will be better able to assure that the rights, safety, and well-being of human subjects are protected; that clinical trials are conducted in accordance with approved plans and with rigor and integrity; and that data derived from clinical trials are reliable.
Extramural Researchers can go here to take the course.
NIH Employees can go here to take the course. (NIH login required)
Educational Facilities can Download the Good Clinical Practices for Social and Behavioral Sciences Course for your educational facility's Learning Management System (LMS).